Home
Prescription
| Product | Pharmaceutical Form | Active ingredient(s) | Strength | Pack size | Description | |
|---|---|---|---|---|---|---|
| Actiq 200μg | Compressed lozenge with integral oromucosal applicator. | Fentanyl | 200μg | 3/6/15/30 | For the management of breakthrough pain in patients already receiving maintenance opioid therapy for chronic cancer pain. Breakthrough pain is a transitory exacerbation of pain that occurs on a background of otherwise controlled persistent pain. | |
| Actiq 400μg | Compressed lozenge with integral oromucosal applicator. | Fentanyl | 400μg | 3/6/15/30 | For the management of breakthrough pain in patients already receiving maintenance opioid therapy for chronic cancer pain. Breakthrough pain is a transitory exacerbation of pain that occurs on a background of otherwise controlled persistent pain. | |
| Actiq 600μg | Compressed lozenge with integral oromucosal applicator. | Fentanyl | 600μg | 3/6/15/30 | For the management of breakthrough pain in patients already receiving maintenance opioid therapy for chronic cancer pain. Breakthrough pain is a transitory exacerbation of pain that occurs on a background of otherwise controlled persistent pain. | |
| Actiq 800μg | Compressed lozenge with integral oromucosal applicator. | Fentanyl | 800μg | 3/6/15/30 | For the management of breakthrough pain in patients already receiving maintenance opioid therapy for chronic cancer pain. Breakthrough pain is a transitory exacerbation of pain that occurs on a background of otherwise controlled persistent pain. | |
| Actiq 1200μg | Compressed lozenge with integral oromucosal applicator. | Fentanyl | 1200μg | 3/6/15/30 | For the management of breakthrough pain in patients already receiving maintenance opioid therapy for chronic cancer pain. Breakthrough pain is a transitory exacerbation of pain that occurs on a background of otherwise controlled persistent pain. | |
| Actiq 1600μg | Compressed lozenge with integral oromucosal applicator. | Fentanyl | 1400μg | 3/6/15/30 | For the management of breakthrough pain in patients already receiving maintenance opioid therapy for chronic cancer pain. Breakthrough pain is a transitory exacerbation of pain that occurs on a background of otherwise controlled persistent pain. | |
| ANSEREN 15MG | Hard capsules | Ketazolam | 15mg | 30 | For the treatment of anxiety, tension and other somatic or psychiatric conditions in association with anxiety disorder. | |
| ANSEREN 30MG | Hard capsules | Ketazolam | 30mg | 15 | For the treatment of anxiety, tension and other somatic or psychiatric conditions in association with anxiety disorder. | |
| ASCORBIC ACID INJECTION | Solution for injection | Ascorbic acid | 500MG/ML | 10 X 5ml | For the prevention and treatment of scurvy, or other conditions requiring vitamin C supplementation. | |
| CYCLIZINE LACTATE | Solution for injection | Cyclizine lactate | 50MG/ML | 5X1ml | For use in adults for the treatment of nausea and vomitting. | |
| Dectancyl 0.5mg | Tablet | Dexamethasone | 0.5mg | 30 | Used in the treatment of the following types of conditions/diseases: Collagen diseases, connective tissue diseases, Dermatological, digestive, endocrine, haematological, infectious, neoplastic, nephrological, neurological, ophthalmological, ENT, respiratory, rheumatological and organ and allogenic hematopoietic stem cell transplant | |
| DELTACORTRIL 1mg | Gastro-resistant tablet | Prednisolone | 1mg | 30s/100s | A steriod medicine prescribed for many conditions such as the following but not limited to: Allergy and anaphylaxsis, arteritis/collagenosis, blood disorders, cardiovascular disorders, endocrine disorders, gastro-intestinal disorders, hypercalcaemia, muscular disorders, neurological disorders, ocular disease, renal disorders, respiratory disease, rheumatic disorders, skin disorders. | |
| DELTACORTRIL 2.5mg | Gastro-resistant tablet | Prednisolone | 2.5mg | 30s/100s | A steriod medicine prescribed for many conditions such as the following but not limited to: Allergy and anaphylaxsis, arteritis/collagenosis, blood disorders, cardiovascular disorders, endocrine disorders, gastro-intestinal disorders, hypercalcaemia, muscular disorders, neurological disorders, ocular disease, renal disorders, respiratory disease, rheumatic disorders, skin disorders. | |
| DELTACORTRIL 5mg | Gastro-resistant tablet | Prednisolone | 5mg | 30s/100s | A steriod medicine prescribed for many conditions such as the following but not limited to: Allergy and anaphylaxsis, arteritis/collagenosis, blood disorders, cardiovascular disorders, endocrine disorders, gastro-intestinal disorders, hypercalcaemia, muscular disorders, neurological disorders, ocular disease, renal disorders, respiratory disease, rheumatic disorders, skin disorders. | |
| Effentora 100μg | Buccal Tablet | Fentanyl | 100μg | 4/28 | For the treatment of breakthrough pain (BTP) in adults with cancer who are already receiving maintenance opioid therapy for chronic cancer pain. BTP is a transitory exacerbation of pain that occurs on a background of otherwise controlled persistent pain. | |
| Effentora 200μg | Buccal Tablet | Fentanyl | 200μg | 4/28 | For the treatment of breakthrough pain (BTP) in adults with cancer who are already receiving maintenance opioid therapy for chronic cancer pain. BTP is a transitory exacerbation of pain that occurs on a background of otherwise controlled persistent pain. | |
| Effentora 400μg | Buccal Tablet | Fentanyl | 400μg | 4/28 | For the treatment of breakthrough pain (BTP) in adults with cancer who are already receiving maintenance opioid therapy for chronic cancer pain. BTP is a transitory exacerbation of pain that occurs on a background of otherwise controlled persistent pain. | |
| Effentora 600μg | Buccal Tablet | Fentanyl | 600μg | 4/28 | For the treatment of breakthrough pain (BTP) in adults with cancer who are already receiving maintenance opioid therapy for chronic cancer pain. BTP is a transitory exacerbation of pain that occurs on a background of otherwise controlled persistent pain. | |
| Effentora 800μg | Buccal Tablet | Fentanyl | 800μg | 4/28 | For the treatment of breakthrough pain (BTP) in adults with cancer who are already receiving maintenance opioid therapy for chronic cancer pain. BTP is a transitory exacerbation of pain that occurs on a background of otherwise controlled persistent pain. | |
| ETOFLAM | Gel | Etofenamate 5% w/w | 5% | 20g/100g | For the treatment of inflammatory disorders of the musculo-skeletal system. | |
| FAMVIR 125MG | Film-coated tablet | Famciclovir | 125mg | 10 | For the treatment of Varicella zoster virus (VZV) infections – herpes zoster and Herpes simplex virus (HSV) infections – genital herpes | |
| FAMVIR 250MG | Film-coated tablet | Famciclovir | 250mg | 15 | For the treatment of Varicella zoster virus (VZV) infections – herpes zoster and Herpes simplex virus (HSV) infections – genital herpes | |
| FAMVIR 500MG | Film-coated tablet | Famciclovir | 500mg | 21 | For the treatment of Varicella zoster virus (VZV) infections – herpes zoster and Herpes simplex virus (HSV) infections – genital herpes | |
| GLYVENOL | Soft capsules | Tribenoside | 400mg | 50 | Treatment of the following conditions: Venous circulatory disorders, Varicose syndrome, Haemorrhoids and as adjuvant therapy in phlebitis, periphlebitis and post-thrombotic syndrome, before and after sclerotherapy of varicose veins. | |
| Hydrocortisone Roussel 10mg | Scored Tablet | Hydrocortisone | 10mg | 25/50 | Used for Glucocorticoid replacement therapy in adrenal insufficiency: ▪ primary adrenal insufficiency: Addison’s disease, adrenalectomy ▪ pituitary-related adrenal insufficiency: Sheehan’s syndrome, pituitary insufficiency due to various causes ▪ congenital adrenal hyperplasia that may or may not be salt-wasting (Debré-Fibiger syndrome). | |
| HYDROXY-VIT | injection | hydroxocobalamin chloride | 1000 µg/ml | 5/10 X 1ml | For the prophylaxis and treatment of anaemia associated with vitamin B12 deficiency. | |
| HYOSCINE INJECTION | Solution for injection | Hyoscine | 400MCG/ML | 5/10 X 1ml | Used as a preoperative medication to control bronchial, nasal pharyngeal and salivary secretions, to prevent bronchospasms and laryngospasm and to block cardiac vagal inhibiting reflexes during induction of anaesthesia and intubation. | |
| OTOSPORIN | Liquid ear drops | Neomycin sulphate 3,400IU, Polymyxin sulphate 10,000IU Hydrocortisone 1% w/v | Neomycin sulphate 3,400IU, Polymyxin sulphate 10,000IU Hydrocortisone 1% w/v | 5/10ml | For the treatment of otitis externa due to, or complicated by, bacterial infection. | |
| PARVOLEX | Concentration for solution for infusion | Acetylcysteine | 200MG/ML | 5/10 X 10ml | For the treatment of paracetamol overdose | |
| PREDNESOL 5MG | Tablet | Prednisolone | 5mg | 20s/30s | Treatment for many conditions such as the following Inflammatory and immunological disorders and Neoplasms Treated with Corticosteroids but not limited to: Inflammatory and Immunological disorders Pemphigus, Asthma, Sarcoid disease, Rheumatoid arthritis, polymyalgia rheumatica and giant cell (temporal) arteritis and polyarteritis nodosa, Systemic lupus erythematosus, Polymyositis, Inflammatory bowel disease: ulcerative colitis and Crohn's disease, Renal disease: minimal change nephrotic syndrome, acute interstitial nephritis; renal lupus, Autoimmune hepatitis, Thrombocytopenic purpura and acquired haemolytic anaemia, Immunosuppression – in organ transplantation Neoplasms Treated with Corticosteriods Acute Lymphoblastic Leukemia (including the acute blastic phase of myeloid leukaemia resembling acute lymphoblastic leukemia), Chronic Lymphocytic Leukemia, Hodgkin Lymphoma, Non-Hodgkin Lymphoma | |
| Priligy 30mg | Film-coated tablet | Dapoxetine Hydrochloride | 30mg | 1/2/3/6 | For the treatment of premature ejaculation (PE) in adult men. | |
| Priligy 60mg | Film-coated tablet | Dapoxetine Hydrochloride | 60mg | 1/2/3/6 | For the treatment of premature ejaculation (PE) in adult men. | |
| PROCTOSEDYL OINTMENT | Cream | Hydrocortisone Cinchocaine Hydrochloride Aesculin Framycetin sulfate | 30G | 1 tube | The local management of pain, pruritus and inflammation associated with internal or external haemorrhoids, and such haemorrhoidal complications as fissures, proctitis, perianal eczema, and post-operative states. | |
| PROCTOSEDYL SUPPOSITORIES | Suppository | Cinchocaine Hydrochloride Hydrocortisone | 5mg | 12 | The local anaesthetic Cinchocaine relieves pain and relaxes sphincteric spasm. Pruritis and inflammation are relieved by Hydrocortisone which also decreases serous discharge. Proctosedyl is, therefore, useful for the short term relief (not more than 7 days) of pain, irritation and pruritis associated with haemorrhoids, pruritis ani. | |
| Profemigr 150 mg | Scored tablet | Ketoprofen | 150mg | For the treatment of migraine attacks with or without aura. | ||
| Profenid 50mg | Capsule | Ketoprofen | 50mg | 20/24 | Long-term symptomatic treatment of Chronic inflammatory rheumatism, notably rheumatoid arthritis, ankylosing spondylitis (or related syndromes, such as Fiessinger-Leroy-Reiter syndrome and psoriatic arthritis) and Certain painful and disabling osteoarthritis. Short-term symptomatic treatment of acute flare-ups of Extra-articular rheumatism such as shoulder periarthritis, tendinitis, bursitis, Microcrystalline arthritis, Osteoarthritis, Low back pain, Radicular pain and Mild acute post-traumatic conditions of the musculoskeletal system. | |
| Profenid 100mg | Suppository | Ketoprofen | 100mg | 10/12 | Long-term symptomatic treatment of Chronic inflammatory rheumatism, notably rheumatoid arthritis, ankylosing spondylitis (or related syndromes, such as Fiessinger-Leroy-Reiter syndrome and psoriatic arthritis) and Certain painful and disabling osteoarthritis. Short-term symptomatic treatment of acute flare-ups of Extra-articular rheumatism such as shoulder periarthritis, tendinitis, bursitis, Microcrystalline arthritis, Osteoarthritis, Low back pain, Radicular pain and Mild acute post-traumatic conditions of the musculoskeletal system. | |
| Profenid 100mg | Film-coated tablet | Ketoprofen | 100mg | 30/100 | Long-term symptomatic treatment of Chronic inflammatory rheumatism, notably rheumatoid arthritis, ankylosing spondylitis (or related syndromes, such as Fiessinger-Leroy-Reiter syndrome and psoriatic arthritis) and Certain painful and disabling osteoarthritis. Short-term symptomatic treatment of acute flare-ups of Extra-articular rheumatism such as shoulder periarthritis, tendinitis, bursitis, Microcrystalline arthritis, Osteoarthritis, Low back pain, Radicular pain and Mild acute post-traumatic conditions of the musculoskeletal system. | |
| BI PROFENID LP 100 mg | Prolonged release tablet | Ketoprofen | 100mg | 20/30/100 | Long-term symptomatic treatment of Chronic inflammatory rheumatism, notably rheumatoid arthritis, ankylosing spondylitis (or related syndromes, such as Fiessinger-Leroy-Reiter syndrome and psoriatic arthritis) and Certain painful and disabling osteoarthritis. Short-term symptomatic treatment of acute flare-ups of Extra-articular rheumatism such as shoulder periarthritis, tendinitis, bursitis, Microcrystalline arthritis, Osteoarthritis, Low back pain, Radicular pain and Mild acute post-traumatic conditions of the musculoskeletal system. | |
| SANDOMIGRAN SCT 0.5MG | Film coated tablet | Pizotifen | 0.5mg | 20s/30s/60s28s/50s/100s | Prophylactic treatment of recurrent vascular headaches, including classical migraine, common migraine and cluster headache (periodic migrainous neuralgia). | |
| SOLPADOL EFFERVESCENT | Effervescent tablet | Paracetamol 500mg Codeine 30mg | 500 mg/30 mg | 4/12/30/32/60/100 | For the relief of severe pain. For the treatment of acute moderate pain which is not considered to be relieved by other analgesics such as paracetamol or ibuprofen (alone). | |
| SOLPADOL CAPLETS | Tablet | Paracetamol 500mg Codeine 30mg | 500 mg/30 mg | 4/10/24/30/60/100 | For the relief of severe pain. For the treatment of acute moderate pain which is not considered to be relieved by other analgesics such as paracetamol or ibuprofen (alone). | |
| Toprec 25mg | Tablet | Ketoprofen | 25mg | 20/100 | For the treatment of painful conditions of mild to moderate intensity and/or febrile illnesses. | |
| VISKEN TAB 15MG | Tablet | Pindolol | 15mg | 15/28/30/60/84/90 | For the treatment of High blood pressure and prophylaxis of effort angina attacks. | |
| VISKEN TAB 5MG | Tablet | Pindolol | 5mg | 50/90/270 | For the treatment of high blood pressure, prophylaxis of effort angina attacks, functional signs of obstructive heart disease, treatment of certain arrhythmias: supraventricular (tachycardia, atrial flutters and fibrillations, junctional tachycardia) or ventricular (ventricular extrasystole, ventricular tachycardia), cardiac symptoms of hyperthyroidism | |
| VITAFEN | Film-coated tablet | Aceclofenac | 100mg | 10/20/30/40/60/100 | For the relief of pain and inflammation in osteoarthritis, rheumatoid arthritis and ankylosing spondylitis. | |
| WARTEC SOLUTION | Topical Solution | Podophyllotoxin | 0.5%W/V | 3ML | For the topical treatment of condylomata acuminata affecting the penis or the external female genitalia. | |
| WARTICON CREAM | Cream | Podophyllotoxin | 0.15% | 5G/10G | For the topical treatment of condylomata acuminata affecting the penis or the external female genitalia. | |
| Zometa | Concentrate for solution for infusion | Zoledronic acid | 4mg/5ml | 1 vial/4 vials | For the prevention of skeletal related events (pathological fractures, spinal compression, radiation or surgery to bone, or tumour-induced hypercalcaemia) in adult patients with advanced malignancies involving bone and the treatment of adult patients with tumour-induced hypercalcaemia (TIH). | |
| Zometa | Solution for Infusion | Zoledronic Acid | 4mg/100ml | 1 bottle/4 bottles | For the prevention of skeletal related events (pathological fractures, spinal compression, radiation or surgery to bone, or tumour-induced hypercalcaemia) in adult patients with advanced malignancies involving bone and the treatment of adult patients with tumour-induced hypercalcaemia (TIH). | |
| Zometa | Powder and solvent for solution for infusion | Zoledronic Acid | 4 mg | 1 vial & 1 ampoule | For the prevention of skeletal related events (pathological fractures, spinal compression, radiation or surgery to bone, or tumour-induced hypercalcaemia) in adult patients with advanced malignancies involving bone and the treatment of adult patients with tumour-induced hypercalcaemia (TIH). |